Cure8 research brief
Why This Matters
Patients who present with new radiologic terminal ileitis sometimes develop Crohn’s disease. Identifying simple blood and imaging markers that predict who is at higher risk could help prioritize follow-up or specialist referral.
Who Should Pay Attention
Emergency and gastroenterology clinicians, researchers studying early Crohn’s markers, and adults with new-onset terminal ileitis or newly diagnosed Crohn’s disease.
Study Snapshot
What To Know
The research analyzed 68 patients seen between 2010–2021 and followed them for one year. On adjusted analysis, lower hemoglobin and higher platelet count were linked to higher odds of a Crohn’s diagnosis, and a combined radiologic finding of stenosis or upstream dilation showed the strongest association.
The authors highlight platelet count and a platelet-to-hemoglobin ratio as having strong discrimination in this sample. The findings are hypothesis-generating: this is a small, single-cohort, retrospective study and the authors explicitly call for prospective external validation before these markers should change clinical practice.
Clinicians may consider these factors when assessing risk but should not use them alone to make diagnostic or treatment decisions.
Keep In Mind
This study is retrospective, small (68 patients), and from a single dataset; it reports associations, not proven predictive rules. The authors recommend prospective validation before clinical adoption.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.